Gossner G - Search Results

1

Value of surgical lymph node assessment for patients with vulvar melanoma.

Giannopoulos S, Naeem S, Nasioudis D, Gossner G, Burke WM, Orfanelli T. Giannopoulos S, et al. Among authors: gossner g. Eur J Cancer. 2024 Oct;210:114303. doi: 10.1016/j.ejca.2024.114303. Epub 2024 Aug 26. Eur J Cancer. 2024. PMID: 39232427

2

Ecological and evolutionary dynamics to design and improve ovarian cancer treatment.

Han GYQ, Alexander M, Gattozzi J, Day M, Kirsch E, Tafreshi N, Chalar R, Rahni S, Gossner G, Burke W, Damaghi M. Han GYQ, et al. Among authors: gossner g. Clin Transl Med. 2024 Sep;14(9):e70012. doi: 10.1002/ctm2.70012. Clin Transl Med. 2024. PMID: 39210542 Free PMC article. Review.

3

Clinical outcome of multidisciplinary treatment of vulvar necrotising fasciitis.

Rabbani AY, Kim S, Gossner G, Burke W, Sandoval S, Krajewski A, Pearl ML. Rabbani AY, et al. Among authors: gossner g. J Wound Care. 2022 Jul 1;31(Sup7):S20-S29. doi: 10.12968/jowc.2022.31.Sup7.S20. J Wound Care. 2022. PMID: 35797247 Review.

4

Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.

Tan L, Wang W, He G, Kuick RD, Gossner G, Kueck AS, Wahl H, Opipari AW, Liu JR. Tan L, et al. Among authors: gossner g. Cancer. 2016 Mar 1;122(5):722-9. doi: 10.1002/cncr.29793. Epub 2015 Nov 30. Cancer. 2016. PMID: 26619367 Free article.

5

Robotic surgery in the obese gynecologic patient.

Burke WM, Gossner G, Goldman NA. Burke WM, et al. Among authors: gossner g. Clin Obstet Gynecol. 2011 Sep;54(3):420-30. doi: 10.1097/GRF.0b013e31822b37b1. Clin Obstet Gynecol. 2011. PMID: 21857172 Review.

6

Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.

Loar P, Wahl H, Kshirsagar M, Gossner G, Griffith K, Liu JR. Loar P, et al. Among authors: gossner g. Am J Obstet Gynecol. 2010 Apr;202(4):371.e1-8. doi: 10.1016/j.ajog.2009.10.883. Am J Obstet Gynecol. 2010. PMID: 20138251

7

Laparoscopy and gynecologic oncology.

Cho JE, Liu C, Gossner G, Nezhat FR. Cho JE, et al. Among authors: gossner g. Clin Obstet Gynecol. 2009 Sep;52(3):313-26. doi: 10.1097/GRF.0b013e3181b088d2. Clin Obstet Gynecol. 2009. PMID: 19661747 Review.

8

Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage.

Wang Y, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM. Wang Y, et al. Among authors: gossner g. J Proteome Res. 2009 Mar;8(3):1452-63. doi: 10.1021/pr800820z. J Proteome Res. 2009. PMID: 19159301 Free PMC article.

9

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

Kim H, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM. Kim H, et al. Among authors: gossner g. Proteomics Clin Appl. 2008 Mar 7;2(4):571-584. doi: 10.1002/prca.200780004. Proteomics Clin Appl. 2008. PMID: 20523764 Free PMC article.

10

Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.

Gossner G, Choi M, Tan L, Fogoros S, Griffith KA, Kuenker M, Liu JR. Gossner G, et al. Gynecol Oncol. 2007 Apr;105(1):23-30. doi: 10.1016/j.ygyno.2006.11.009. Epub 2007 Jan 17. Gynecol Oncol. 2007. PMID: 17234261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters